Shi R, Du Q, Yao C, Huang D, et al. The Germline HSD3B1 Variant Is Associated With Response to Androgen Deprivation Therapy and Abiraterone but not With Response to Enzalutamide in Chinese Prostate Cancer Patients. Prostate 2025 Nov 4. doi: 10.1002/pros.70089.
PMID: 41186130